Van Dyke M W, Roeder R G
Nucleic Acids Res. 1987 Jul 10;15(13):5031-9. doi: 10.1093/nar/15.13.5031.
Partially-purified preparations of transcription factor TFIIIC derived from either cytoplasmic (S100) or nuclear (NE) HeLa cell extracts possessed comparable activities when assayed by in vitro transcription, although it was possible to detect sequence-specific binding to the VAI RNA gene promoter by DNase I footprinting only with TFIIIC (NE). On the basis of mixing experiments, this difference could not be ascribed to either transcriptional or DNA-binding inhibitors. These findings provide further evidence for the existence of two forms of TFIIIC: one which is present in both extracts and is transcriptionally active; another which predominates in nuclear extracts and is transcriptionally inactive.
从细胞质(S100)或细胞核(NE)的HeLa细胞提取物中获得的转录因子TFIIIC部分纯化制剂,在体外转录分析时具有相当的活性,尽管仅用TFIIIC(NE)通过DNA酶I足迹法才能检测到与VAI RNA基因启动子的序列特异性结合。基于混合实验,这种差异不能归因于转录抑制剂或DNA结合抑制剂。这些发现为存在两种形式的TFIIIC提供了进一步的证据:一种存在于两种提取物中且具有转录活性;另一种在细胞核提取物中占主导且无转录活性。